IDENTIFICATION OF HIGH HEMOGLOBIN LEVELS AS A RISK FACTOR AMONG THE PREGNANT WOMEN HAVING HIGH BLOOD SUGAR LEVELS

Not Applicable

Completed

• Conditions: Health Condition 1: O992- Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium

• Registration Number: CTRI/2021/05/033387
• Lead Sponsor: JSS COLLEGE OF PHARMACY OOTY

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2021-08-15
• Last Update Posted: 17 October 2022

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 216

Inclusion Criteria

Maternal age: 18 years to 40 years

Women with a singleton pregnancy

Gestation period: 13th week to 28th week (pregnant women of second trimester)

Patient taking Routine treatment (Folic acid 0.5mg + FeSo4 335mg (100 mg of elemental iron) OD in the morning 2. Calcium 500 mg OD in the noon 3. Vitamin b complex (vitB1 2mg, vit B2 2mg, vit B6 0.5mg, Niacinamide 25mg Calcium Pantothenate 1mg ) daily during gestational period.

The patient will be screened for hemoglobin levels, Fasting blood glucose, postprandial blood glucose, and Random blood glucose and Oral glucose tolerance test.

Exclusion Criteria

Chronic hypertension, kidney and liver diseases, pre-pregnancy diabetes mellitus, immunological and inflammatory diseases, thromboembolism, and chronic or active infections.

Cardiac diseases, thyroid abnormalities, and known peptic ulcers, esophagitis, gastritis, or hiatus hernia.

History of high-risk pregnancy including abruption placenta, placenta previa, coagulation disorders, thrombocytopenia, or history of drug abuse.

Previous stillborn fetus.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To evaluate whether elevated Hemoglobin level is associated as a risk factor of developing GDM in comparison with normal levels of Hemoglobin among women attending the antenatal check at Government Medical College and Hospital, Ooty.Timepoint: 6 months

Secondary Outcome Measures

Name	Time	Method
To assess other blood parameters those, influence the risk of developing GDM.Timepoint: 6 months